BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32045367)

  • 1. Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.
    Huang S; Zhang C; Sun C; Hou Y; Zhang Y; Tam NL; Wang Z; Yu J; Huang B; Zhuang H; Zhou Z; Ma Z; Sun Z; He X; Zhou Q; Hou B; Wu L
    Aging (Albany NY); 2020 Feb; 12(3):3025-3041. PubMed ID: 32045367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.
    Hou Y; Wang Z; Huang S; Sun C; Zhao J; Shi J; Li Z; Wang Z; He X; Tam NL; Wu L
    Cell Death Dis; 2019 Dec; 10(12):929. PubMed ID: 31804459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.
    Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exportin-T promotes tumor proliferation and invasion in hepatocellular carcinoma.
    Lin J; Hou Y; Huang S; Wang Z; Sun C; Wang Z; He X; Tam NL; Wu C; Wu L
    Mol Carcinog; 2019 Feb; 58(2):293-304. PubMed ID: 30334580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling.
    Bai L; Yu Z; Zhang J; Yuan S; Liao C; Jeyabal PV; Rubio V; Chen H; Li Y; Shi ZZ
    Oncotarget; 2016 Mar; 7(9):10402-13. PubMed ID: 26863455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined OLA1 and CLEC3B Gene Is a Prognostic Signature for Hepatocellular Carcinoma and Impact Tumor Progression.
    Chen Z; Zeng L; Chen Z; Xu J; Zhang X; Ying H; Zeng Y; Yu F
    Technol Cancer Res Treat; 2024; 23():15330338241241935. PubMed ID: 38564315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways.
    Chen T; Huang H; Zhou Y; Geng L; Shen T; Yin S; Zhou L; Zheng S
    J Exp Clin Cancer Res; 2018 Aug; 37(1):193. PubMed ID: 30111352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OLA1, a Translational Regulator of p21, Maintains Optimal Cell Proliferation Necessary for Developmental Progression.
    Ding Z; Liu Y; Rubio V; He J; Minze LJ; Shi ZZ
    Mol Cell Biol; 2016 Oct; 36(20):2568-82. PubMed ID: 27481995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cell-matrix adhesion by OLA1, the Obg-like ATPase 1.
    Jeyabal PV; Rubio V; Chen H; Zhang J; Shi ZZ
    Biochem Biophys Res Commun; 2014 Feb; 444(4):568-74. PubMed ID: 24486488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression.
    Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X
    Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
    Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cells.
    Bian R; Zhao J; Yao Z; Cai Y; Shou C; Lou D; Zhou L; Qian Y
    J Gastrointest Oncol; 2022 Jun; 13(3):1255-1265. PubMed ID: 35837205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma.
    Zhu Y; Ke KB; Xia ZK; Li HJ; Su R; Dong C; Zhou FM; Wang L; Chen R; Wu SG; Zhao H; Gu P; Leung KS; Wong MH; Lu G; Zhang JY; Jiang BH; Qiu JG; Shi XN; Lin MC
    Mol Med; 2021 Feb; 27(1):15. PubMed ID: 33579185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.
    Sun J; Wang X; Shen Q; Wang M; Chen S; Zhang X; Huang Y; Zhang Z; Li W; Yuan Y; Huang Z
    Cell Oncol (Dordr); 2022 Dec; 45(6):1187-1202. PubMed ID: 36327092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.